61 results
8-K
EX-1.1
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(x) Compliance with Healthcare Laws. The Company … applicable foreign healthcare related fraud and abuse laws, including, without limitation, the federal Anti-kickback Statute (42 U.S.C. § 1320a-7b(b
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
19 Mar 24
Intra-cellular Therapies Announces Executive Appointments and Leadership Changes
8:44am
to work with him in his new role as we further build on our commercial success and advance our broad pipeline.”
Mr. Halstead is a seasoned healthcare
8-K
5jxmmg1wxdpl uq9e
21 Apr 22
Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
8:08am
8-K
EX-1.1
pvba 8uebpy
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
424B5
07exn
5 Jan 22
Prospectus supplement for primary offering
4:51pm
424B5
t0i8ou22 8iv
3 Jan 22
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
373 69r2j30
20 Dec 21
Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults
7:04am
8-K
EX-99.1
s2ju0 5sv
10 May 21
Intra-cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:37am